Transferrin Saturation - Clinical Significance

Your Result

Transferrin saturation: 60% (reference range: 20-50%)

This is the single most concerning result in your blood work.

flowchart TD
    subgraph Ranges["TSAT Ranges"]
        NORM["20-45%: Normal range"]
        ELEV["45-60%: Elevated"]
        HIGH["Above 60%: High risk"]
    end

    NORM --> SAFE["No NTBI expected"]
    SAFE --> ROUTINE["Routine monitoring"]

    ELEV --> THRESH["NTBI generation threshold"]
    THRESH --> INVEST["Investigate: iron studies"]
    INVEST --> DIET["Dietary modification"]

    HIGH --> NTBI["NTBI likely present"]
    NTBI --> ORGAN["Organ damage risk"]
    ORGAN --> PHLEB["Phlebotomy indicated"]
    ORGAN --> MRI["Hepatic iron MRI"]
    ORGAN --> MONITOR["3-6 month monitoring"]

    classDef safe fill:#58d68d,stroke:#1e8449,color:#0a1f12
    classDef caution fill:#f7dc6f,stroke:#b7950b,color:#1a1400
    classDef danger fill:#f1948a,stroke:#c0392b,color:#1a0505
    classDef action fill:#85c1e9,stroke:#2471a3,color:#0a1929

    class NORM,SAFE,ROUTINE safe
    class ELEV,THRESH,INVEST,DIET caution
    class HIGH,NTBI,ORGAN danger
    class PHLEB,MRI,MONITOR action

What Transferrin Saturation Means

Transferrin is the blood protein that safely transports iron. Under normal conditions, only 20-50% of transferrin's iron-binding sites are occupied. When saturation rises above ~45-50%, the system begins to overflow.

The NTBI Threshold

Non-transferrin bound iron (NTBI) is iron circulating in the blood NOT safely bound to transferrin. It is the primary mediator of iron toxicity.

"NTBI species appear when transferrin saturation exceeds approximately 45%, and become consistently detectable above 60-70%" — Breuer et al., Transfus Sci. 2000;23(3):185-192

"Many disorders of iron homeostasis are associated with dynamic kinetic profiles of multiple NTBI species, chronic exposure to which can drive organ damage" — Garbowski et al., Am J Hematol. 2023;98(3):533-540. DOI: 10.1002/ajh.26819

At your TSAT of 60%, you are at the threshold where NTBI is likely present in your plasma.

Labile Plasma Iron (LPI)

LPI is the redox-active, most toxic fraction of NTBI:

• Generates reactive oxygen species (ROS) via Fenton chemistry
• Directly damages cell membranes, DNA, and proteins
• Targets liver, heart, pancreas, joints, and endocrine organs

Duca L et al. "The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity" — Int J Mol Sci. 2025;26(13):6433. PMC12249652

NTBI in HFE Haemochromatosis

Ryan E et al. "NTBI levels in C282Y homozygotes after therapeutic phlebotomy" — EJHaem. 2022;3(3):644-652. PMC9422009

• NTBI is detectable in HH patients even after phlebotomy when TSAT remains elevated
• Target TSAT < 50% to minimise NTBI exposure

Clinical Guidelines for Your Situation

EASL Guidelines (2022)

For non-C282Y homozygotes (including compound hets) with elevated TSAT and ferritin:

• TSAT > 45% in females or > 50% in males: investigate further
• Ferritin > 200 ug/L (females) or > 300 ug/L (males): with elevated TSAT, confirms provisional iron overload
• If non-C282Y/C282Y: hepatic iron quantification (MRI T2* or FerriScan) or liver biopsy required for formal diagnosis

Your Numbers vs Thresholds

What Should Happen Next

1. Hepatic iron MRI (T2/FerriScan)*: Non-invasive quantification of liver iron concentration

   • Indicated because: non-homozygous genotype + elevated iron parameters
   • Would confirm or exclude hepatic iron overload
   • Normal hepatic iron concentration (HIC): < 36 umol/g dry weight

2. Consider therapeutic phlebotomy: Even in compound hets, if iron parameters remain elevated

   • Target: ferritin 50-100 ug/L, TSAT < 50%
   • Frequency: typically 1-2 units every 2-4 weeks initially, then maintenance

3. Monitoring schedule (if not starting phlebotomy):

   • Serum ferritin and TSAT every 6-12 months minimum
   • LFTs annually
   • Consider FerriScan if ferritin rises above 500 again

The Phlebotomy Question

Adams PC. "How I treat hemochromatosis." Blood. 2010;116(3):317-325.

• All patients with ferritin > 300 ug/L (males) and TSAT > 50% should be considered for phlebotomy
• This applies regardless of genotype if iron overload is confirmed

HFE hemochromatosis therapeutic recommendations — Hematol Transfus Cell Ther. 2022

• Phlebotomy remains the gold standard for iron removal
• Diet alone is insufficient for clinical iron overload (you've proven this — dropped from 700 to 380 but plateaued)

Important Context: Your Diet Has Helped But Plateaued

You reduced ferritin from ~700 to 380 through dietary changes alone. This is significant — but:

• TSAT remains at 60% (still above range)
• Ferritin at 380 is still high-normal
• Diet can reduce iron intake but cannot actively remove stored iron
• Phlebotomy is the only way to actively deplete iron stores

See Dietary Management - Iron Overload for what you're doing right and what else can help.

Key References

1. Breuer W et al. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci. 2000;23(3):185-192
2. Garbowski MW et al. Clinical relevance of detectable plasma iron species in iron overload. Am J Hematol. 2023;98(3):533-540
3. Duca L et al. NTBI, LPI, and iron toxicity. Int J Mol Sci. 2025;26(13):6433
4. Ryan E et al. NTBI levels in C282Y homozygotes. EJHaem. 2022;3(3):644-652
5. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. 2022
6. Adams PC. How I treat hemochromatosis. Blood. 2010;116(3):317-325
7. Patel M, Ramavataram DVS. Non-transferrin bound iron. Indian J Clin Biochem. 2012;27(4):322-332. PMC3477448
8. Silva AMN, Rangel M. The (Bio)Chemistry of non-transferrin-bound iron. Molecules. 2022;27:1784

Cross-References

• Blood Results - March 2026
• HFE Compound Heterozygosity
• Iron Overload and NTBI
• Dietary Management - Iron Overload
• Ceruloplasmin and Ferroxidase Activity
• Action Items and Monitoring Plan